Back to Journals » Journal of Hepatocellular Carcinoma

Impact Factor

Journal of Hepatocellular Carcinoma

ISSN: 2253-5969


       

Journal Articles:

- 610 records -

Original Research

The Potential of the lncRNAs ADAMTSL4-AS1, AC067931 and SOCS2-AS1 in Peripheral Blood Mononuclear Cells as Novel Diagnostic Biomarkers for Hepatitis B Virus-Associated Hepatocellular Carcinoma

Guan W, Zhang C, Miao T, Dong C, Li L, Yuan X, Zhao D, Ai R, Zhang X, Sun M, Kang H, Nan Y

Journal of Hepatocellular Carcinoma 2024, 11:1221-1233

Published Date: 27 June 2024

Original Research

The Influence of Visceral Adiposity on Overall Survival: Exploring “Obesity Paradox” Among Hepatocellular Carcinoma Patients Who Receiving Immunotherapy

Zhou Y, Ouyang J, Yang H, Wang Z, Yang Y, Li Q, Zhao H, Zhou J, Li Q

Journal of Hepatocellular Carcinoma 2024, 11:1193-1206

Published Date: 24 June 2024

Original Research

Radiomics-Based Prediction of Microvascular Invasion Grade in Nodular Hepatocellular Carcinoma Using Contrast-Enhanced Magnetic Resonance Imaging

Zhang Z, Jia XF, Chen XY, Chen YH, Pan KH

Journal of Hepatocellular Carcinoma 2024, 11:1185-1192

Published Date: 21 June 2024

Review

GDF15: Immunomodulatory Role in Hepatocellular Carcinoma Pathogenesis and Therapeutic Implications

Du YN, Zhao JW

Journal of Hepatocellular Carcinoma 2024, 11:1171-1183

Published Date: 19 June 2024

Original Research

PD-1 Inhibitors Combined with Tyrosine Kinase Inhibitors with or without Hepatic Artery Infusion Chemotherapy for the First-Line Treatment of HBV-Related Advanced Hepatocellular Carcinoma: A Retrospective Study

Wang D, Zhang Z, Yang L, Zhao L, Liu Z, Lou C

Journal of Hepatocellular Carcinoma 2024, 11:1157-1170

Published Date: 18 June 2024

Review

Research Progress on the Role of Epigenetic Methylation Modification in Hepatocellular Carcinoma

Wang J, Gao W, Yu H, Xu Y, Bai C, Cong Q, Zhu Y

Journal of Hepatocellular Carcinoma 2024, 11:1143-1156

Published Date: 17 June 2024

Original Research

Establishing and Externally Validating a Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) Score-Based Nomogram for Predicting Early Recurrence in BCLC Stage 0/A Hepatocellular Carcinoma Patients After Radical Liver Resection: A Multi-Center Study

Liu X, Qiu Z, Ndhlovu E, Wan Y, Sun H, Wang S, Cao Y, Zhu P

Journal of Hepatocellular Carcinoma 2024, 11:1127-1141

Published Date: 14 June 2024

Original Research

Incorporating Inflammatory Markers and Clinical Indicators into a Predictive Model of Single Small Hepatocellular Carcinoma Recurrence After Primary Locoregional Treatments

Qiao W, Xiong Y, Li K, Jin R, Zhang Y

Journal of Hepatocellular Carcinoma 2024, 11:1113-1125

Published Date: 13 June 2024

Original Research

Circ_0007386 Promotes the Progression of Hepatocellular Carcinoma Through the miR-507/ CCNT2 Axis

Feng Y, Liang L, Jia W, Wang J, Xu C, Zhu D, Xu B, Zhao W, Ling X, Zhou Y, Kong L, Ding W

Journal of Hepatocellular Carcinoma 2024, 11:1095-1112

Published Date: 13 June 2024

Original Research

Transarterial Chemoembolization Combined with Atezolizumab Plus Bevacizumab versus Transarterial Chemoembolization Alone in Intermediate‐stage Hepatocellular Carcinoma: A Multicenter Retrospective Study

Zheng Y, Xiang Y, Shi H, Lin Z, Cheng S, Zhu J

Journal of Hepatocellular Carcinoma 2024, 11:1079-1093

Published Date: 12 June 2024

Original Research

Efficacy and Safety of Transarterial Chemoembolization and Repeated Partial Splenic Embolization for Hepatocellular Carcinoma with Hypersplenism and Thrombocytopenia

Hong W, Wang Z, Yao W, Zhang X, Zhang L, Liang B

Journal of Hepatocellular Carcinoma 2024, 11:1065-1078

Published Date: 11 June 2024

Original Research

Development and Validation of a Novel Prognostic Nomogram Based on Platelet and CD8+T Cell Counts in Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombosis

Shi W, Yan H, Liu X, Yu L, Xie Y, Wu Y, Liang Y, Yang Z

Journal of Hepatocellular Carcinoma 2024, 11:1049-1063

Published Date: 7 June 2024

Original Research

LAYN Serves as a Prognostic Biomarker and Downregulates Tumor-Infiltrating CD8+ T Cell Function in Hepatocellular Carcinoma

Xiao S, Lu L, Lin Z, Ye X, Su S, Zhang C, You Y, Li W, Huang X, Wu W, Zhou Y

Journal of Hepatocellular Carcinoma 2024, 11:1031-1048

Published Date: 6 June 2024

Original Research

Changes in Posttreatment Spleen Volume Associated with Immunotherapy Outcomes for Advanced Hepatocellular Carcinoma

Chen BB, Liang PC, Shih TTF, Liu TH, Shen YC, Lu LC, Lin ZZ, Hsu C, Hsu CH, Cheng AL, Shao YY

Journal of Hepatocellular Carcinoma 2024, 11:1015-1029

Published Date: 5 June 2024

Case report

Prolonged Complete Remission Using Tislelizumab for Hepatocellular Carcinoma After Adjuvant Chemotherapy Failure: A Case Report

Zhu X, Dong S, Tang J, Xie R, Wu H, Guan J, Hu S

Journal of Hepatocellular Carcinoma 2024, 11:1005-1013

Published Date: 4 June 2024

Rapid Communication

A Comparison of Presentation, Treatment, and Survival After Hepatocellular Carcinoma of Viral and Non-Viral Etiology in Damietta, Egypt, 2007–2019

Jean K, Tawheed A, Luong Nguyen LB, Heikal T, Eldaly U, Elhadidy NG, Elghaieb A, Aboudonia A, Tondeur L, Dublineau A, Fontanet A, El-Kassas M

Journal of Hepatocellular Carcinoma 2024, 11:997-1004

Published Date: 31 May 2024

Review

CRISPR in Targeted Therapy and Adoptive T Cell Immunotherapy for Hepatocellular Carcinoma

Palaz F, Ozsoz M, Zarrinpar A, Sahin I

Journal of Hepatocellular Carcinoma 2024, 11:975-995

Published Date: 30 May 2024

Expert Opinion

A Post-International Gastrointestinal Cancers’ Conference (IGICC) Position Statements

Yalcin S, Lacin S, Kaseb AO, Peynircioğlu B, Cantasdemir M, Çil BE, Hurmuz P, Doğrul AB, Bozkurt MF, Abali H, Akhan O, Şimşek H, Sahin B, Aykan FN, Yücel İ, Tellioğlu G, Selçukbiricik F, Philip PA

Journal of Hepatocellular Carcinoma 2024, 11:953-974

Published Date: 29 May 2024

Original Research

Prediction of Microvascular Invasion and Recurrence After Curative Resection of LI-RADS Category 5 Hepatocellular Carcinoma on Gd-BOPTA Enhanced MRI

Zhang J, Li Y, Xia J, Pan X, Lu L, Fu J, Jia N

Journal of Hepatocellular Carcinoma 2024, 11:941-952

Published Date: 25 May 2024

Original Research

Preoperative Antiviral Therapy and Long-Term Outcomes for Hepatitis B Virus-Related Hepatocellular Carcinoma After Curative Liver Resection: A Multicenter Analysis

Dai MG, Liu SY, Zhu L, Lu WF, Xie GL, Liang L, Liu JW, Ye B

Journal of Hepatocellular Carcinoma 2024, 11:927-939

Published Date: 23 May 2024

Original Research

A Novel Nomogram to Predict Prognosis of Advanced Hepatocellular Carcinoma Treated with Intensity-Modulated Radiotherapy Plus Anti-PD1

He M, Liang C, Pang Y, Jiang M, Long M, Yao Z, Wang X, Zhang R, Wu Q, Liang S, Li J

Journal of Hepatocellular Carcinoma 2024, 11:913-925

Published Date: 22 May 2024

Original Research

A Novel Nomogram to Predict Prognosis in Elderly Early-Stage Hepatocellular Carcinoma Patients After Ablation Therapy

Tang X, Wang Q, Jin R, Hu C

Journal of Hepatocellular Carcinoma 2024, 11:901-911

Published Date: 17 May 2024

Original Research

Integration of Single-Cell RNA Sequencing and Bulk RNA Sequencing to Identify an Immunogenic Cell Death-Related 5-Gene Prognostic Signature in Hepatocellular Carcinoma

Peng L, Xu S, Xu JL

Journal of Hepatocellular Carcinoma 2024, 11:879-900

Published Date: 16 May 2024

Original Research

Construction of a Prognostic Model for Hepatocellular Carcinoma Based on Macrophage Polarization-Related Genes

Chen H, Li J, Cao D, Tang H

Journal of Hepatocellular Carcinoma 2024, 11:857-878

Published Date: 11 May 2024

Original Research

Mechanisms of Sorafenib Resistance in HCC Culture Relate to the Impaired Membrane Expression of Organic Cation Transporter 1 (OCT1)

Chava S, Ekmen N, Ferraris P, Aydin Y, Moroz K, Wu T, Thung SN, Dash S

Journal of Hepatocellular Carcinoma 2024, 11:839-855

Published Date: 9 May 2024

Original Research

PVALB Was Identified as an Independent Prognostic Factor for HCC Closely Related to Immunity, and Its Absence Accelerates Tumor Progression by Regulating NK Cell Infiltration

Gong Y, Zhou M, Zhu Y, Pan J, Zhou X, Jiang Y, Zeng H, Zheng H, Geng X, Huang D

Journal of Hepatocellular Carcinoma 2024, 11:813-838

Published Date: 8 May 2024

Original Research

Patterns, Risk Factors, and Outcomes of Recurrence After Hepatectomy for Hepatocellular Carcinoma with and without Microvascular Invasion

Yu Y, Wang XH, Hu WJ, Chen DH, Hu ZL, Li SQ

Journal of Hepatocellular Carcinoma 2024, 11:801-812

Published Date: 8 May 2024

Original Research

CXCL9 Overexpression Predicts Better HCC Response to Anti-PD-1 Therapy and Promotes N1 Polarization of Neutrophils

Wang P, Xu MH, Xu WX, Dong ZY, Shen YH, Qin WZ

Journal of Hepatocellular Carcinoma 2024, 11:787-800

Published Date: 8 May 2024

Original Research

A Modified Targetoid Feature Emphasizing Thin-Rim APHE to Improve the Diagnostic Performance of LI-RADS for Malignant Hepatic Tumors

Huang R, Zheng C, Xu G, Chen X, Shen J, Mao S

Journal of Hepatocellular Carcinoma 2024, 11:775-786

Published Date: 26 April 2024

Original Research

Clinical Characteristics of Non-B and Non-C Biopsy-Proven Primary Liver Cancers in an HBV- Endemic Area: A Retrospective Study

Hu Z, Zhou H

Journal of Hepatocellular Carcinoma 2024, 11:767-774

Published Date: 24 April 2024

Original Research

A Novel Four-Gene Signature Based on Nonsense-Mediated RNA Decay for Predicting Prognosis in Hepatocellular Carcinoma: Bioinformatics Analysis and Functional Validation

Zhao J, Wang C, Zhao L, Zhou H, Wu R, Zhang T, Ding J, Zhou J, Zheng H, Zhang L, Kong T, Zhou J, Hu Z

Journal of Hepatocellular Carcinoma 2024, 11:747-766

Published Date: 23 April 2024

Original Research

Triglyceride-Glucose Index is an Independent Risk Factor for Hepatocellular Carcinoma Development in Patients with HBV-Related Liver Cirrhosis

Yang SH, He YS, Zheng SQ, Zhang XJ, Dai H, Xue Y

Journal of Hepatocellular Carcinoma 2024, 11:737-746

Published Date: 18 April 2024

Original Research

Adjuvant Transarterial Chemoembolization Plus Immunotherapy for Huge Hepatocellular Carcinoma: A Propensity Score Matching Cohort Study

Huang H, Liao W, Zhang K, Wang H, Cheng Q, Mei B

Journal of Hepatocellular Carcinoma 2024, 11:721-735

Published Date: 8 April 2024

Review

Macroscopic Characterization of Hepatocellular Carcinoma: An Underexploited Source of Prognostic Factors

Gonvers S, Martins-Filho SN, Hirayama A, Calderaro J, Phillips R, Uldry E, Demartines N, Melloul E, Park YN, Paradis V, Thung SN, Alves V, Sempoux C, Labgaa I

Journal of Hepatocellular Carcinoma 2024, 11:707-719

Published Date: 6 April 2024

Original Research

Development and Validation of a Nomogram for Patients Undergoing Transarterial Chemoembolization for Recurrent Hepatocellular Carcinoma After Hepatectomy

Xie D, Li Z, Yuan J, Yin X, Chen R, Zhang L, Ren Z

Journal of Hepatocellular Carcinoma 2024, 11:693-705

Published Date: 4 April 2024

Original Research

Machine Learning Model Based on the Neutrophil-to-Eosinophil Ratio Predicts the Recurrence of Hepatocellular Carcinoma After Surgery

Shao G, Ma Y, Qu C, Gao R, Zhu C, Qu L, Liu K, Li N, Sun P, Cao J

Journal of Hepatocellular Carcinoma 2024, 11:679-691

Published Date: 3 April 2024

Original Research

Hepatic Arterial Infusion Chemotherapy vs Transcatheter Arterial Chemoembolization as Adjuvant Therapy Following Surgery for MVI-Positive Hepatocellular Carcinoma: A Multicenter Propensity Score Matching Analysis

Wen Y, Lu L, Mei J, Ling Y, Guan R, Lin W, Wei W, Guo R

Journal of Hepatocellular Carcinoma 2024, 11:665-678

Published Date: 4 April 2024

Original Research

High-Risk Hepatocellular Carcinoma: Hepatic Arterial Infusion Chemotherapy versus Transarterial Chemoembolization

Zhang B, Huang B, Yang F, Yang J, Kong M, Wang J, Xiang Y, Wang K, Peng R, Yang K, An C, Yan D

Journal of Hepatocellular Carcinoma 2024, 11:651-663

Published Date: 27 March 2024

Review

The State of Systematic Therapies in Clinic for Hepatobiliary Cancers

Chen W, Hu Z, Li G, Zhang L, Li T

Journal of Hepatocellular Carcinoma 2024, 11:629-649

Published Date: 27 March 2024

Original Research

The Influence of Drug-Eluting Beads Transarterial Chemoembolization on Serum Levels of Soluble Programmed Cell Death Protein-1 in Advanced Hepatocellular Carcinoma Patients

Ma X, Sun X, Xie F, Jian W, Wang Q, Xie Y, Li C, Zhang K

Journal of Hepatocellular Carcinoma 2024, 11:619-628

Published Date: 25 March 2024

Original Research

Development of a Reliable GADSAH Model for Differentiating AFP-negative Hepatic Benign and Malignant Occupying Lesions

Long X, Zeng H, Zhang Y, Lu Q, Cao Z, Shu H

Journal of Hepatocellular Carcinoma 2024, 11:607-618

Published Date: 23 March 2024

Original Research

Enhancement Pattern Mapping for Early Detection of Hepatocellular Carcinoma in Patients with Cirrhosis

Nikzad N, Fuentes DT, Roach M, Chowdhury T, Cagley M, Badawy M, Elkhesen A, Hassan M, Elsayes KM, Beretta L, Koay EJ, Jalal PK

Journal of Hepatocellular Carcinoma 2024, 11:595-606

Published Date: 20 March 2024

Review

Advances in the Pathogenesis of Metabolic Liver Disease-Related Hepatocellular Carcinoma

Chen P, Li Y, Dai Y, Wang Z, Zhou Y, Wang Y, Li G

Journal of Hepatocellular Carcinoma 2024, 11:581-594

Published Date: 19 March 2024

Original Research

Plumbagin Regulates Snail to Inhibit Hepatocellular Carcinoma Epithelial-Mesenchymal Transition in vivo and in vitro

Du YQ, Yuan B, Ye YX, Zhou FL, Liu H, Huang JJ, Wei YF

Journal of Hepatocellular Carcinoma 2024, 11:565-580

Published Date: 19 March 2024

Corrigendum

Prognostic Effect of Sarcopenia in Hepatocellular Carcinoma Patients Targeted with Interventional Therapy Combined with Immunotherapy and Targeted Therapy [Corrigendum]

Yang H, Cong T, Luo Y, Yang C, Ren J, Li X

Journal of Hepatocellular Carcinoma 2024, 11:563-564

Published Date: 14 March 2024

Original Research

LncRNA MEG3 Reduces the Ratio of M2/M1 Macrophages Through the HuR/CCL5 Axis in Hepatocellular Carcinoma

Wei H, Wu X, Huang L, Long C, Lu Q, Huang Z, Huang Y, Li W, Pu J

Journal of Hepatocellular Carcinoma 2024, 11:543-562

Published Date: 11 March 2024

Original Research

A Hypoxia-Related miRNA-mRNA Signature for Predicting the Response and Prognosis of Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma

Zong S, Huang G, Pan B, Zhao S, Ling C, Cheng B

Journal of Hepatocellular Carcinoma 2024, 11:525-542

Published Date: 12 March 2024

Original Research

Machine Learning-Based Nomogram for Predicting Overall Survival in Elderly Patients with Cirrhotic Hepatocellular Carcinoma Undergoing Ablation Therapy

Qiao W, Sheng S, Li J, Jin R, Hu C

Journal of Hepatocellular Carcinoma 2024, 11:509-523

Published Date: 7 March 2024

Original Research

Construction and Validation of a Novel Nomogram Predicting Recurrence in Alpha-Fetoprotein-Negative Hepatocellular Carcinoma Post-Surgery Using an Innovative Liver Function-Nutrition-Inflammation-Immune (LFNII) Score: A Bicentric Investigation

Zhang BL, Liu J, Diao G, Chang J, Xue J, Huang Z, Zhao H, Yu L, Cai J

Journal of Hepatocellular Carcinoma 2024, 11:489-508

Published Date: 6 March 2024

Original Research

Efficacy and Safety of HepaSphere Drug-Eluting Bead Transarterial Chemoembolization Combined with Hepatic Arterial Infusion Chemotherapy as the Second-Line Treatment in Advanced Hepatocellular Carcinoma

Liu B, Gao S, Guo J, Kou F, Liu S, Zhang X, Feng A, Wang X, Cao G, Chen H, Liu P, Xu H, Gao Q, Yang R, Xu L, Zhu X

Journal of Hepatocellular Carcinoma 2024, 11:477-488

Published Date: 4 March 2024

More articles